Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

Mohamed A. Kharfan-Dabaja; Michael D. Jain; Sonikpreet Aulakh; Ernesto Ayala; Abba C. Zubair; Han W. Tun; Hien D. Liu; Frederick L. Locke; Julio C. Chavez

doi:10.1002/ajh.25560

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

Mohamed A. Kharfan-Dabaja, Michael D. Jain, Sonikpreet Aulakh, Ernesto Ayala, Abba C. Zubair, Han W. Tun, Hien D. Liu, Frederick L. Locke, Julio C. Chavez

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E245-E247
Journal	American journal of hematology
Volume	94
Issue number	9
DOIs	https://doi.org/10.1002/ajh.25560
State	Published - Sep 2019

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25560

Cite this

@article{8c74486a91c644d4850fad6b3b8d05fb,

title = "Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells",

author = "Kharfan-Dabaja, {Mohamed A.} and Jain, {Michael D.} and Sonikpreet Aulakh and Ernesto Ayala and Zubair, {Abba C.} and Tun, {Han W.} and Liu, {Hien D.} and Locke, {Frederick L.} and Chavez, {Julio C.}",

year = "2019",

month = sep,

doi = "10.1002/ajh.25560",

language = "English (US)",

volume = "94",

pages = "E245--E247",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

AU - Kharfan-Dabaja, Mohamed A.

AU - Jain, Michael D.

AU - Aulakh, Sonikpreet

AU - Ayala, Ernesto

AU - Zubair, Abba C.

AU - Tun, Han W.

AU - Liu, Hien D.

AU - Locke, Frederick L.

AU - Chavez, Julio C.

PY - 2019/9

Y1 - 2019/9

UR - http://www.scopus.com/inward/record.url?scp=85068504795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068504795&partnerID=8YFLogxK

U2 - 10.1002/ajh.25560

DO - 10.1002/ajh.25560

M3 - Letter

C2 - 31211433

AN - SCOPUS:85068504795

SN - 0361-8609

VL - 94

SP - E245-E247

JO - American journal of hematology

JF - American journal of hematology

IS - 9

ER -

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this